TABLE-Haba Laboratories Inc - 9-MTH group results

About this update from Haba Laboratories, Inc.

Feb 13 (Reuters)- Haba Laboratories Inc CONSOLIDATED FINANCIAL HIGHLIGHTS (in billions of yen unless specified) 9 months ended 9 months ended Year to Dec 31, 2025 Dec 31, 2024 Mar 31, 2026 LATEST YEAR-AGO LATEST RESULTS RESULTS FORECAST Sales 8.72 8.61 12.55 (+1.3 pct) (-0.3 pct) (+4.0 pct) Operating 513 mln 221 mln 500 mln (+132.4 pct) (-15.2 pct) Recurring 501 mln 236 mln 490 mln (+112.5 pct) (-19.5 pct) Net 318 mln 220 mln 480 mln (+44.2 pct) (-16.7 pct) EPS 84.24 yen 58.42 yen 126.93 yen Ann Div 40.00 yen 40.00 yen -Q2 div NIL NIL -Q4 div 40.00 yen 40.00 yen NOTE - Haba Laboratories Inc. To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4925.T

View stock analysis, news, and events for Haba Laboratories, Inc.